A Phase I Trial Combining Triapine with Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Disease Sites:

Neuro-Oncology

Staging:

Phase I

Age Group:

Adults

Therapies:

Mol. targeted/Immunotherapy/Biologics, Radiotherapy

Drugs:

Radiation, Triapine

Principal Investigator(s):

Merrell, Ryan

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

09-18-2025

Trial Type:

Treatment

Protocol ID:

VICC-NTNEU24156P

National Clinical Trial ID:

NCT06860594

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available